App is temporarily unavailable
Description
术愈App是一款为肺部肿瘤手术患者提供院外康复管理的软件。
基于AI、大数据、物联网等技术，可为肿瘤患者提供身体状态评估、症状监测及干预、康复训练以及心理和营养支持等“大医学”范畴下的一体化院外治疗及康复管理方案，提升患者的治疗获益。
基于AI、大数据、物联网等技术，可为肿瘤患者提供身体状态评估、症状监测及干预、康复训练以及心理和营养支持等“大医学”范畴下的一体化院外治疗及康复管理方案，提升患者的治疗获益。
Screenshots
术愈-肺部肿瘤康复管理 FAQ
-
Is 术愈-肺部肿瘤康复管理 free?
Yes, 术愈-肺部肿瘤康复管理 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 术愈-肺部肿瘤康复管理 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 术愈-肺部肿瘤康复管理 cost?
术愈-肺部肿瘤康复管理 is free.
-
What is 术愈-肺部肿瘤康复管理 revenue?
To get estimated revenue of 术愈-肺部肿瘤康复管理 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Israel yet.
Ratings History
术愈-肺部肿瘤康复管理 Reviews
术愈-肺部肿瘤康复管理 Installs
Last 30 days
术愈-肺部肿瘤康复管理 Revenue
Last 30 days术愈-肺部肿瘤康复管理 Revenue and Downloads
Gain valuable insights into 术愈-肺部肿瘤康复管理 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- TriC Healthcare (Wuxi) Co
- Languages
- Chinese, English
- Recent release
- 1.0.5 (2 years ago )
- Released on
- Oct 11, 2021 (3 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 8 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.